Literature DB >> 10358166

IgMhighCD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells.

A M Oliver1, F Martin, J F Kearney.   

Abstract

Ag encounter will recruit Ag-specific cells from the pool of mature B lymphocytes in the spleen and activate them to perform effector functions: generation of Ab-forming cells (plasma cells) and presentation of Ag to T cells. We have compared the ability of mature follicular and marginal zone cells to develop into effector B cells. The generation of marginal zone B cells and their localization in the marginal sinus area are T cell and CD40 ligand independent, suggesting that they do not represent a postgerminal center population. Compared with mature recirculating follicular B cells, they express several characteristics of previous antigenic experience, including higher levels of B7.1 (CD80) and B7.2 (CD86) when freshly isolated and following in vitro stimulation. After a brief 6- to 8-h in vitro stimulation with LPS or anti-CD40 Abs, marginal zone B cells become potent APCs. In addition, their ability to proliferate and differentiate into plasma cells in response to low doses of T-independent polyclonal stimuli (LPS) is far greater than that of follicular B cells. These findings indicate a functional heterogeneity within splenic mature B lymphocytes, with marginal zone B cells having the capacity to generate effector cells in early stages of the immune response against particulate Ags scavenged efficiently in this special anatomical site.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358166

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  113 in total

1.  Recruitment of a distinct but related set of VH sequences into the murine CD21hi/CD23- marginal zone B cell repertoire to that seen in the class-switched antibody response.

Authors:  Henry N White; Qing-Hai Meng
Journal:  J Immunol       Date:  2011-12-02       Impact factor: 5.422

2.  Polyreactive antigen-binding B (PAB-) cells are widely distributed and the PAB population consists of both B-1+ and B-1- phenotypes.

Authors:  Z-H Zhou; A L Notkins
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

3.  Specific in vivo deletion of B-cell subpopulations expressing human immunoglobulins by the B-cell superantigen protein L.

Authors:  Muriel Viau; Nancy S Longo; Peter E Lipsky; Lars Björck; Moncef Zouali
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.

Authors:  Colleen M Witt; Vincent Hurez; C Scott Swindle; Yoshio Hamada; Christopher A Klug
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

5.  Neural signaling in the spleen controls B-cell responses to blood-borne antigen.

Authors:  Paola Mina-Osorio; Mauricio Rosas-Ballina; Sergio I Valdes-Ferrer; Yousef Al-Abed; Kevin J Tracey; Betty Diamond
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

6.  The transcription factor Bright plays a role in marginal zone B lymphocyte development and autoantibody production.

Authors:  Athenia L Oldham; Cathrine A Miner; Hong-Cheng Wang; Carol F Webb
Journal:  Mol Immunol       Date:  2011-10-02       Impact factor: 4.407

7.  SHEP1 partners with CasL to promote marginal zone B-cell maturation.

Authors:  Cecille D Browne; Melanie M Hoefer; Suresh K Chintalapati; Matthew H Cato; Yann Wallez; Derek V Ostertag; Elena B Pasquale; Robert C Rickert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-18       Impact factor: 11.205

8.  Reduced c-myc expression levels limit follicular mature B cell cycling in response to TLR signals.

Authors:  Almut Meyer-Bahlburg; Ashok D Bandaranayake; Sarah F Andrews; David J Rawlings
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 9.  Effects of acute and chronic inflammation on B-cell development and differentiation.

Authors:  Derek Cain; Motonari Kondo; Huaiyong Chen; Garnett Kelsoe
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

10.  Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide.

Authors:  Jason W Johnston; Lisa E Myers; Martina M Ochs; William H Benjamin; David E Briles; Susan K Hollingshead
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.